Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
Comparative Trial of Standard Versus Low-dose Peg-Interferon Plus Ribavirin in the Treatment of Chronic Hepatitis C
The purpose of this study is to evaluate the efficacy and safety of low-dose
 interferon-alfa-2b plus ribavirin compared to the standard-dose of the same combination in
 patients with chronic hepatitis C.
Inclusion Criteria:

 -  Clinical diagnosis of Chronic Hepatitis C. Must be infected with genotype 1b viruses

 Exclusion Criteria:

 -  Hemoglobin levels<8.5g/dL,

 -  Platelet counts<50,000/mm3,

 -  Total polymorphonuclear counts<1000/mm3

 -  Pregnancy,

 -  Renal dysfunction,